Add-on doxofylline to improve lung function in stable COPD
Part of Lungs & breathing clinical trials.
This trial tests whether adding doxofylline to your usual inhalers can improve lung function and breathing tests in people with stable COPD. It may help if your COPD is moderate to worse and you have been stable for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed COPD diagnosis for at least 6 months
- Your lung breathing test shows FEV1 is 80% or less of what’s expected
- You have a smoking history of at least 10 pack-years (active or former smoker)
- You are already using a LAMA and a LABA inhaler regularly, with or without an inhaled steroid
- Your COPD has been clinically stable for the past 6 months
- You can safely do breathing tests and a 6-minute walk test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early trial tests whether inhaled nitric oxide changes how well your lungs exchange gases during exercise in people with COPD, and compares results with healthy volunteers. It may help researchers understand lung blood-flow and breathing differences that could affect symptoms and exercise tolerance.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This trial tests if inhaled corticosteroids (ICS) work better for COPD patients with different eosinophil levels. You must already be taking two long-acting bronchodilators and have stopped smoking for at least 6 months.
This study tests whether breathing extra oxygen during outpatient pulmonary rehabilitation helps people with COPD. Participants will have their oxygen levels checked during exercise to see if extra oxygen improves their rehab results.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.